POXEL FRANCE Price to Book Ratio 2019-2020 | PXXLF
Historical price to book ratio values for POXEL FRANCE (PXXLF) over the last 10 years. The current price to book ratio for POXEL FRANCE as of October 15, 2021 is 5.26.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|POXEL FRANCE Price/Book Ratio Historical Data
||Book Value per Share
||Price to Book Ratio
||Medical - Biomedical and Genetics
Poxel SA is a biopharmaceutical company. It offers drugs for metabolic diseases such as diabetes and related metabolic disorders. The company's product pipeline consists of Imeglimin, PXL770 and PXL007 which are in clinical trial stage. Poxel SA is headquartered in Lyon, France.